Kyle Jenne

Kyle Jenne

EVP, Chief Global Product Strategy OfficeratIonis Pharmaceuticals· In proxies 2022–2024

Pay in FY2023-100% from the year before · Ionis Pharmaceuticals stock +33.9% the same year

Kyle Jenne was paid $0 in FY2023 (Dec), down 100%. Ionis Pharmaceuticals stock rose 33.9% that year.

Pay$100 in the stock at the end of FY21 → $166
Pay is from the Summary Compensation Table of each Ionis Pharmaceuticals proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Experience

  1. Ionis PharmaceuticalsPublic company · 4 yr
    • EVP, Chief Global Product Strategy Officer2022 – Present · 4 yrStock in role +44%

Roles come from the proxy statements of each company.

Activity

For the press:Download CSVDownload PNGHow to use our data

Two people shown as one, or a wrong number?